and so is your budget

    ATTENTION: Waste Classifications Now Reflect EPA’s Final Rule: Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine.
    By selecting your state, if your state has not yet adopted the Rule, your waste classification should reflect the prior recommendations.
    Please let us know if that is not the case.


    PharmEcology provides a one-stop solution to help your organization identify, segregate, manage, and dispose of pharmaceutical waste in a compliant and cost-effective manner. We now offer a unique Assessment of Risk customized to your inventory as required by USP <800>.

    The Latest Industry News

    Tailored Services

    PharmEcology's services are part of a larger concept, a total solution individualized to address the unique circumstances of your facility.

    Proven Expertise

    The PharmEcology team has 30 years of experience managing pharmaceutical waste streams in the healthcare environment.

    Total Compliance

    PharmEcology's customized services coupled with our industry knowledge ensure compliance in a cost effective manner.

    Industries We Serve

    Acute Care Hospitals

    Acute Care Hospitals are the most complex organizations in which to develop and maintain a pharmaceutical waste management program. Learn how over 500 acute care hospitals have addressed this complexity with the PharmEcology solutions.

    Ambulatory Surgery Centers

    While Ambulatory Surgery Centers typically do not generate large quanities of pharmaceutical waste, they still must meet environmental regulations and Joint Commission standards. Learn how PharmEcology has the ability to scale to the needs of any sized organization and ensure they meet compliance.

    Long Term Care Facilities

    Long Term Care facilities offer unique challenges when designing a cost effective and compliant pharmaceutical waste program. Learn how our work with the DEA, EPA, and related professional associations lead to a compliant and simple to use solution.

    LTCF Provider Pharmacies

    Provider Pharmacies often have to handle unknown and unplanned pharmaceuticals returned from their customers leading to potential problems when disposal is required. Learn how PharmEcology's Waste Wizard gives 24/7 access to proper disposal information and requirements.

    Medical Clinics

    Medical clinics may only stock hundreds of drugs yet are required to meet the same environmental and Joint Commission standards as hospitals. Learn how PharmEcology can provide a cost effective solution while ensuring compliance.

    Retail Pharmacies

    The cornerstone to the PharmEcology solution is the input from PharmEcologists® who have years of experience working in retail pharmacies and understand the constraints of a busy, high volume store.

    The PharmEcology Advantage

    • Industry-leading PharmEcologist® teams experienced in compliance and waste categorization

    • Access to the PharmE® Waste Wizard®, a web-based search engine that provides 24/7 access to drug waste categorization information, including state hazardous waste designations down to the product level

    • Remote and on-site training and education to help your staff learn how to segregate pharmaceutical waste

    The Latest Industry News

    MODERNA COVID-19 Vaccine Disposal Guidance

    PharmEcology, a division of WM Sustainability Services, is pleased to publish MODERNA COVID-19 Vaccine Disposal Guidance

    Pfizer-BioNTech COVID-19 Vaccine Disposal Guidance

    PharmEcology, a division of WM Sustainability Services, is pleased to publish Pfizer-BioNTech COVID-19 Vaccine Disposal Guidance

    PharmEcology® Provides Disposal Guidelines for the 2020-2021 Flu Season

    PharmEcology, a division of WM Sustainability Services, is pleased to publish a summary of the proper flu vaccine disposal guidelines for the 2020-2021 flu season as a public service to the healthcare community.

    NIOSH 2020: Key Impacts on Your Organization!

    On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH) released the long-awaited proposed “NIOSH List of Hazardous Drugs in Healthcare Settings, 2020”, as well as “Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings” and “Managing Hazardous Drug Exposures: Information for Healthcare Settings” in the Federal Register.

    PharmEcology - Twenty Years and Counting!

    PharmEcology Services was founded on August 1, 2000, which in today’s world seems like ancient history. It’s also ancient history in terms of how pharmaceutical waste is managed by healthcare facilities today.

    Comment Deadline Looming June 30, 2020 on NIOSH 2020 List and Documents

    Pharmacy Practice News recently published a summary by PharmEcology regulatory staff of the three documents provided for comment in the Federal Register on May 1, 2020.

    NIOSH Publishes Proposed 2020 Hazardous Drug List and Procedures

    NIOSH has published for comment the long awaited revised 2020 Hazardous Drug List along with information for managing hazardous drug exposure and the NIOSH procedures for developing the list.

    How to Register under EPA’s Subpart P on Form 8700-12

    As an increasing number of states adopt EPA’s new hazardous waste pharmaceuticals rule, 40 CFR 266 Subpart P, healthcare facilities will be challenged to determine if they must register with EPA.

    EPA Authorizes Alternate PHRM Code on Manifest

    Based on concerns expressed by industry regarding the inability of healthcare facilities to list the entire PHARMS code in Item 13 required under the new 266 Subpart P Hazardous Waste Pharmaceuticals which went into effect in non-authorized states August 21, 2019, EPA has issued an alternate code, PHRM, which fits into the paper hazardous waste manifest which is still in common usage.

    EPA’s New Hazardous Waste Pharmaceutical Rule: Top Takeaways

    EPA’s New Hazardous Waste Pharmaceutical Rule - Top Takeaways

    EPA Signs New Management Standards for Hazardous Waste Pharmaceuticals

    EPA has issued the pre-publication version of its Final Rule on the management of hazardous waste pharmaceuticals with the following summary: SUMMARY: Some pharmaceuticals are regulated as hazardous waste under the Resource Conservation and Recovery Act (RCRA) when discarded.

    PharmEcology Launches USP <800> Assessment of Risk Consulting Service

    With the December 1, 2019 deadline for USP <800> compliance only a year away, PharmEcology Services, WMSS is launching a unique consulting service which leverages the PharmEcology database to provide a customized Assessment of Risk (A of R) for clients based on their Inventory Analysis along with an A of R algorithm that enables healthcare facilities to customize relevant decisions, including the use of personal protective equipment (PPE), containment strategies, etc.

    The EPA’s e-Manifest system for tracking hazardous waste is now in effect as of July 1, 2018

    On July 1, 2018 EPA launched its Hazardous Waste Electronic Manifest System, known as e-Manifest, for the tracking of hazardous waste, including hazardous waste pharmaceuticals, from the generator through to final disposal.

    The Joint Commission (TJC) to focus on pharmaceutical wastage during surveys beginning January 1, 2018

    According to the standards described below, The Joint Commission will focus on pharmaceutical wastage of controlled substances as well as hazardous pharmaceutical wastage with a focus on applicable diversion prevention strategies.

    USP Announces Delay in Implementation of USP <800> to December 1, 2019

    USP made the announcement of the implementation delay on its website on September 29th, 2017 as follows:

    Important Updates

    USP is announcing the intent to postpone the official date of General Chapter <800>.

    EPA Hazardous Waste Generator Improvements Rule Effective Federally May 30, 2017

    The EPA Hazardous Waste Generator Improvements Rule became effective federally May 30, 2017. It is therefore active in Iowa and Alaska, two states that operate under federal EPA authority.

    NIOSH 2016 List Updates

    The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Healthcare Settings was published originally in September 2004 in which NIOSH identified a sample list of major hazardous drugs. The list was updated in 2010, 2012, 2014 and most recently in September 2016.

    PharmEcology Launches New State-Specific Website

    PharmEcology Services, a business unit of WM Sustainability Services, is pleased to announce our new website and database to better serve our clients.

    New Increased EPA RCRA Civil Penalty Authority

    In 2015, Congress raised the penalty authority regarding a number of statutes, including the Resource Conservation and Recovery Act

    EPA Announces Publication of the Final Rule: Hazardous Waste Generator Improvements

    The EPA Administrator signed the Final Rule: Hazardous Waste Generator Improvements on October 28, 2016 and it was published in the Federal Register (FR) on November 28, 2016.

    NIOSH Publishes 2016 Hazardous Drug List

    NIOSH has published its biennial update of the hazardous drug list and continued its practice of offering three tables of products: 

    • Group 1: Antineoplastic drugs; 
    • Group 2: Non-antineoplastic drugs that meet one or more of the NIOSH criteria for a hazardous drug; and 
    • Group3: Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breast feeding

    OSHA Updates Hazardous Drug Handling Website

    OSHA has updated its 1999 Technical Manual on handling hazardous drugs